Down-staging after two different preoperative chemoradiation schedules in rectal cancer

Tumori

Volumn 89, Issue 2, 2003, Pages 164-167

  Grillo Ruggieri, Filippo ^a   Mantello, Giovanna ^a   Cardinali, Massimo ^a   Fabbietti, Letizia ^a   Fenu, Francesco ^a   Montisci, María ^a   Bracci, Raffaella ^a   Delprete, Stefano ^b   Guerrieri, Mario ^b   Marmorale, Cristina ^a  

^a Azienda Ospedaliera Umberto I   (Italy)

^b Azienda Ospedaliera Umberto I   (Italy)

Author keywords

Down staging; Preoperative chemoradiation; Rectal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C; RADIOSENSITIZING AGENT;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMPARATIVE STUDY; CONTINUOUS INFUSION; FEMALE; GASTROINTESTINAL TOXICITY; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; RECTUM CANCER; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0038207102     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900211     Document Type: Article

References (12)

1. Grann A, Feng C, Wong D, Saltz L, Paty PP, Guillem JG, Cohen AM, Minsky BD: Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys, 49: 987-995, 2001.
2. Minsky BD, Cohen AM, Enker WE, Paty P: Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys, 31: 553-559, 1995.
3. Kaminsky-Forret MC, Conroy T, Luporsi E, Peiffert D, Lapeyre M, Boissel P, Guillemin F, Bey P: Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys, 42: 935-941, 1998.
4. Janjan NA, Abbruzzese J, Pazdur R, Khoo VS, Cleary K, Dubrow R, Ajani J, Rich TA, Goswitz MS, Evetts PA, Allen PK, Lynch PM, Skibber JM: Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol, 51: 153-160, 1999.
5. Mohiuddin M, Hayne M, Regine WF, Hanna N, Hagihara PF, McGrath P, Marks G: Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys, 48: 1075-1080, 2000.
6. Minsky BD: Adjuvant therapy of rectal cancer - radiation therapy considerations. ASCO Educational Book, pp 425-439, 1998.
7. UICC International Union Against Cancer. TNM classification of malignant tumours, 5th edition, 1997.
8. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer, 47: 207-214, 1981.
9. Mandard AM, Dalibard F, Mandard JC: Pathologic assessment of tumour regression after preoperative chemo-radiotherapy of oesophageal carcinoma. Clinic-pathologic correlations. Cancer, 73: 2680-86, 1994.
10. Mohiuddin M, Regine WF, John WJ, Hagihara PF, McGrath PC, Kenady DE, Marks G: Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys, 46: 883-888, 2000.
11. Valentini V, Coco C, Cellini N, Picciocchi A, Rosetto ME, Mantini G, Marmiroli L, Barbaro B, Cogliandolo S, Nuzzo G, Tedesco M, Ambesi-Impiombato F, Cosimelli M, Rotman M: Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumour response, and sphincter preservation. Int J Radiat Oncol. Biol Phys, 45: 1175-1184, 1999.
12. Valentini V, Coco C, Cellini N, Picciocchi A, Fares MC, Rosetto ME, Mantini G, Morganti AG, Barbaro B, Cogliandolo S, Nuzzo G, Tedesco M, Ambesi-Impiombato F, Cosimelli M, Rotman M: Ten years of preoperative chemoradiation for extra peritoneal T3 rectal cancer: acute toxicity, tumour response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys, 51: 371-383, 2001.